Esmolol patient counseling information: Difference between revisions
Jump to navigation
Jump to search
Ahmed Zaghw (talk | contribs) Created page with "__NOTOC__ {{Esmolol}} {{CMG}}; {{AE}} {{AZ}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER ..." |
Ahmed Zaghw (talk | contribs) No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AZ}} | {{CMG}}; {{AE}} {{AZ}} | ||
==Patient Counseling Information== | |||
Physicians should inform patients of the risks associated with BREVIBLOC injection: | |||
The most common adverse reactions are : | |||
:*Symptomatic [[hypotension]] (hyperhidrosis, dizziness):*Asymptomatic hypotension.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=595cc3d5-1306-4828-aefa-5595219ffd62 | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== | ||
{{Reflist}} | {{Reflist}} |
Revision as of 19:50, 4 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Patient Counseling Information
Physicians should inform patients of the risks associated with BREVIBLOC injection:
The most common adverse reactions are :
- Symptomatic hypotension (hyperhidrosis, dizziness):*Asymptomatic hypotension.[1]
References
Adapted from the FDA Package Insert.